Needham has upgraded Masimo Corp MASI to Buy from Hold with a $205 price target.
- According to analyst Mike Matson, the selloff in the stock following the company's Sound United acquisition was "overdone" as the deal should prove to be highly accretive to earnings.
- On 16 February, Masimo shares closed 37% lower at $144.62.
- Related: Masimo Stock Plunges After Q4 Results, Sound United Deal.
- Matson adds that Masimo's revenue guidance appears conservative as the Company laps easier for 2021 comps while expanding oximetry into lower-acuity settings should drive increased growth.
- After Q4 earnings, Piper Sandler downgraded Masimo from Overweight to Neutral and lowered the price target from $330 to $200.
- However, UBS maintained Masimo with a Buy and lowered the price target from $325 to $295.
- Price Action: MASI shares are up 1.79% at $155.11 during the market session on the last check Friday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: NewsUpgradesHealth CarePrice TargetAnalyst RatingsMoversTrading IdeasGeneralBriefsHealth CareHealth Care Equipment
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in